Vascular Screening Devices

Global Vascular Screening Devices Market to Reach US$2.2 Billion by 2030

The global market for Vascular Screening Devices estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Portable Vascular Screening Devices, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Standalone Vascular Screening Devices segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$458.9 Million While China is Forecast to Grow at 7.8% CAGR

The Vascular Screening Devices market in the U.S. is estimated at US$458.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$444.3 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Vascular Screening Devices Market - Key Trends & Drivers Summarized

Why Are Vascular Screening Devices Becoming Central to Preventive Cardiovascular Care?
Vascular screening devices are gaining rapid adoption as public health systems pivot toward early detection and intervention in cardiovascular disease (CVD), the leading cause of mortality globally. These devices are used to non-invasively assess the presence of vascular abnormalities such as arterial stiffness, plaque buildup, and reduced blood flow-conditions often preceding strokes, heart attacks, and peripheral artery disease (PAD). Technologies include portable Doppler ultrasound systems, pulse wave velocity analyzers, ankle-brachial index (ABI) systems, and photoplethysmography tools that enable fast, point-of-care assessments.

The increased incidence of lifestyle-related risk factors-including diabetes, hypertension, and obesity-has amplified the role of vascular screening in both primary care and specialist clinics. Demand is also being fueled by employer-sponsored health screenings, government-led chronic disease programs, and direct-to-consumer wellness initiatives. Patients aged over 50, particularly men and post-menopausal women, form the primary demographic undergoing carotid artery and peripheral vascular screening. By identifying vascular irregularities early, these devices help stratify patients by risk, guide preventive therapies, and reduce long-term healthcare costs tied to acute cardiac events.

How Are Innovations in Device Design and Functionality Expanding Market Reach?
Technology is playing a pivotal role in transforming vascular screening from a specialist function into a routine diagnostic. New devices are smaller, faster, and designed for use by non-specialists. Handheld ultrasound scanners with AI-assisted image interpretation are enabling general practitioners and nurse practitioners to screen patients in primary care settings. ABI measurement tools with automated cuff inflation and built-in interpretation algorithms are being deployed in pharmacies and mobile clinics, expanding accessibility for at-risk populations in rural and underserved areas.

The integration of vascular screening into digital health platforms is also transforming follow-up care and patient engagement. Devices now interface with cloud-based patient records, enabling clinicians to track vascular health longitudinally, compare results, and guide medication adherence or lifestyle modifications. Wearable tech is emerging as an adjunct tool, with companies developing PPG-based devices that monitor vascular tone and pulse waveform irregularities in real time. Moreover, AI-powered diagnostics and risk stratification models are increasing the predictive accuracy of vascular screening, allowing health systems to triage patients more effectively and personalize care pathways.

Where Is Demand for Vascular Screening Accelerating Most Rapidly?
The demand for vascular screening devices is strongest in North America and Europe, where health systems are heavily focused on CVD prevention and chronic disease management. The U.S. market benefits from a high prevalence of private health check programs and value-based reimbursement models that reward early detection. In Europe, national screening initiatives for PAD and atrial fibrillation have created robust demand for point-of-care vascular diagnostics. Additionally, aging populations across the EU are driving consistent demand for non-invasive vascular health monitoring tools in both ambulatory and home settings.

In Asia-Pacific, rising healthcare awareness and improving diagnostic infrastructure are contributing to accelerated adoption. Countries such as Japan, South Korea, India, and China are experiencing increased deployment of vascular screening tools in urban clinics and telemedicine networks. Middle Eastern healthcare systems are also integrating such devices into diabetes and hypertension management programs, especially in Gulf countries with high CVD burden. NGOs and government health missions in Africa and Latin America are introducing portable vascular screening tools in community health camps, often supported by donor agencies and mobile health platforms.

What Is Fueling the Growth of the Global Vascular Screening Devices Market?
The growth in the vascular screening devices market is driven by several factors, including the rising global burden of cardiovascular disease, the shift toward preventive healthcare, and the increasing accessibility of point-of-care diagnostics. As healthcare systems seek to reduce hospitalization rates and long-term care costs, screening tools that can detect vascular anomalies early are gaining strategic importance. The proliferation of ambulatory care centers, mobile health units, and employer-based wellness programs is further enhancing distribution and utilization of these devices.

Technological convergence-combining imaging, artificial intelligence, and mobile health-is expanding the applicability of vascular screening beyond hospitals into community settings and home care. Regulatory approvals and standardization efforts are also strengthening clinician confidence and reimbursement potential, particularly for ABI and carotid ultrasound tools. With consumer interest in health monitoring at an all-time high, and wearable innovation on the rise, vascular screening is poised to become a routine part of wellness management. Combined with policy shifts toward value-based care, these dynamics ensure sustained global growth for the vascular screening devices market in the years ahead.

SCOPE OF STUDY:

The report analyzes the Vascular Screening Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Portable Vascular Screening Devices, Standalone Vascular Screening Devices); End-User (Hospitals End-User, Diagnostic Centers / Clinics End-User, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• CorVascular Diagnostics
• Toshiba (Canon Medical)
• AngioScreen (Angiology Corp. of America)
• BD (Becton Dickinson)
• Biotronik
• Boston Scientific
• Cardinal Health
• Abbott (Cardiovascular Diagnostic)
• FUKUDA Denshi
• GE HealthCare (Vivid Cardiovascular)
• LeMaitre Vascular
• Life Line Screening
• Medtronic
• Shenzhen Mindray Bio-Medical Electronics
• Mindray
• OMRON
• Probo Medical
• Siemens Healthineers
• Terumo
• Unetixs Vascular

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.